research funding

ucla-faculty-gets-big-win-in-suit-against-trump’s-university-attacks

UCLA faculty gets big win in suit against Trump’s university attacks


Government can’t use funding threats to override the First Amendment.

While UCLA has been most prominently targeted by the Trump Administration, the ruling protects the entire UC system. Credit: Myung J. Chun

On Friday, a US District Court issued a preliminary injunction blocking the United States government from halting federal funding at UCLA or any other school in the University of California system. The ruling came in response to a suit filed by groups representing the faculty at these schools challenging the Trump administration’s attempts to force UCLA into a deal that would substantially revise instruction and policy.

The court’s decision lays out how the Trump administration’s attacks on universities follow a standard plan: use accusations of antisemitism to justify an immediate cut to funding, then use the loss of money to compel an agreement that would result in revisions to university instruction and management. The court finds that this plan was deficient on multiple grounds, violating legal procedures for cutting funding to an illegal attempt and suppressing the First Amendment rights of faculty.

The result is a reprieve for the entire University of California system, as well as a clear pathway for any universities to fight back against the Trump administration’s attacks on research and education.

First Amendment violations

The Judge overseeing this case, Rita Lin, issued separate documents describing the reasoning behind her decision and the sanctions she has placed on the Trump administration. In the first, she lays out the argument that the threats facing the UC system, and most notably UCLA, are part of a scripted campaign deployed against many other universities, one that proceeds through several steps. The Trump administration’s Task Force to Combat Anti-Semitism is central to this effort, which starts with the opening of a civil rights investigation against a university that was the site of anti-Israel protests during the conflict in Gaza.

“Rooting out antisemitism is undisputedly a laudable and important goal,” Judge Lin wrote. But the investigations in many cases take place after those universities have already taken corrective steps, which the Trump administration seemingly never considers. Instead, while the investigations are still ongoing, agencies throughout the federal government cancel funding for research and education meant for that university and announce that there will be no future funding without an agreement.

The final step is a proposed settlement that would include large payments (over $1.2 billion in UCLA’s case) and a set of conditions that alter university governance and instruction. These conditions often have little to no connection with antisemitism.

While all of this was ostensibly meant to combat antisemitism, the plaintiffs in this case presented a huge range of quotes from administration officials, including the head of the Task Force to Combat Anti-Semitism, saying the goal was to suppress certain ideas on campus. “The unrebutted record in this case shows that Defendants have used the threat of investigations and economic sanctions to… coerce the UC to stamp out faculty, staff, and student ‘woke,’ ‘left,’ ‘anti-American,’ ‘anti-Western,’ and ‘Marxist’ speech,” Lin said.

And even before any sort of agreement was reached, there was extensive testimony that people on campus changed their teaching and research to avoid further attention from the administration. “Plaintiffs’ members express fear that researching, teaching, and speaking on disfavored topics will trigger further retaliatory funding cancellations against the UC,” Lin wrote, “and that they will be blamed for the retaliation. They also describe fears that the UC will retaliate against them to avoid further funding cuts or in order to comply with the proposed settlement agreement.”

That’s a problem, given that teaching and research topics are forms of speech, and therefore protected by the First Amendment. “These are classic, predictable First Amendment harms, and exactly what Defendants publicly said that they intended,” Lin concluded.

Beyond speech

But the First Amendment isn’t the only issue here. The Civil Rights Act, most notably Title VI, lays out a procedure for cutting federal funding, including warnings and hearings before any funds are shut off. That level of coercion is also limited to cases where there’s an indication that voluntary compliance won’t work. Any funding cut would need to target the specific programs involved and the money allocated to them. There is nothing in Title VI that enables the sort of financial payments that the government has been demanding (and, in some cases, receiving) from schools.

It’s pretty obvious that none of these procedures are being followed here. And as Lin noted in her ruling, “Defendants conceded at oral argument that, of the billions of dollars of federal university funding suspended across numerous agencies in recent months, not a single agency has followed the procedures required by Title VI and IX.”

She found that the government decided it wasn’t required to follow the Civil Rights Act procedures. (Reading through the decision, it becomes hard to tell where the government offered any defense of its actions at all.)

The decision to ignore all existing procedures, in turn, causes additional problems, including violations of the Tenth Amendment, which limits the actions that the government can take. And it runs afoul of the Administrative Procedures Act, which prohibits the government from taking actions that are “arbitrary and capricious.”

All of this provided Lin with extensive opportunities to determine that the Plaintiffs, largely organizations that represent the faculty at University of California schools, are likely to prevail in their suit, and thus are deserving of a preliminary injunction to block the federal government’s actions. But first, she had to deal with a recent Supreme Court precedent holding that cases involving federal money belong in a different court system. She did so by arguing that this case is largely about First Amendment and federal procedures rather than any sort of contract for federal money; money is being used as a lever here, so they ruling must involve restoring the money to address the free speech issues.

That issue will undoubtedly be picked up on appeal as it makes its way through the courts.

Complete relief

Lin identified a coercive program that is being deployed against many universities and is already suppressing speech throughout the University of California system, including on campuses that haven’t been targeted yet. She is issuing a ruling that targets the program broadly.

“Plaintiffs have shown that Defendants are coercing the [University of California] as a whole, through the Task Force Policy and Funding Cancellation, to stamp out their members’ disfavored speech,” Lin concluded. “Therefore, to afford Plaintiffs complete relief, the entirety of the coercive practice must be enjoined, not just the suspensions that impact Plaintiffs’ members.”

Her ruling indicates that if the federal government decides it wants to cut any grants to any school in the UC system, it has to go through the entire procedure set out in the Civil Rights Act. The government is also prohibited from demanding money from any of these schools as a fine or payment, and it can’t threaten future funding to the schools. The current hold on grants to the school by the government must also be lifted.

In short, the entire UC system should be protected from any of the ways that the government has been trying to use accusations of antisemitism to suppress ideas that it disfavors. And since those primarily involve federal funding, that has to be restored, and any future threats to it must be blocked.

While this case is likely to face a complicated appeals process, Lin’s ruling makes it extremely clear that all of these cases are exactly what they seemed. Just as members of the administration stated in public multiple times, they decided to target some ideas they disfavored and simply made up a process that would let them do so.

While it worked against a number of prominent universities, its legal vulnerabilities have been there from the start.

Photo of John Timmer

John is Ars Technica’s science editor. He has a Bachelor of Arts in Biochemistry from Columbia University, and a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley. When physically separated from his keyboard, he tends to seek out a bicycle, or a scenic location for communing with his hiking boots.

UCLA faculty gets big win in suit against Trump’s university attacks Read More »

trump-offers-universities-a-choice:-comply-for-preferential-funding

Trump offers universities a choice: Comply for preferential funding

On Wednesday, The Wall Street Journal reported that the Trump administration had offered nine schools a deal: manage your universities in a way that aligns with administration priorities and get “substantial and meaningful federal grants,” along with other benefits. Failure to accept the bargain would result in a withdrawal of federal programs that would likely cripple most universities. The offer, sent to a mixture of state and private universities, would see the government dictate everything from hiring and admissions standards to grading and has provisions that appear intended to make conservative ideas more welcome on campus.

The document was sent to the University of Arizona, Brown University, Dartmouth College, Massachusetts Institute of Technology, the University of Pennsylvania, the University of Southern California, the University of Texas, Vanderbilt University, and the University of Virginia. However, independent reporting indicates that the administration will ultimately extend the deal to all colleges and universities.

Ars has obtained a copy of the proposed “Compact for Academic Excellence in Higher Education,” which makes the scope of the bargain clear in its introduction. “Institutions of higher education are free to develop models and values other than those below, if the institution elects to forego federal benefits,” it suggests, while mentioning that those benefits include access to fundamental needs, like student loans, federal contracts, research funding, tax benefits, and immigration visas for students and faculty.

It is difficult to imagine how it would be possible to run a major university without access to those programs, making this less a compact and more of an ultimatum.

Poorly thought through

The Compact itself would see universities agree to cede admissions standards to the federal government. The government, in this case, is demanding only the use of “objective” criteria such as GPA and standardized test scores as the basis of admissions decisions, and that schools publish those criteria on their websites. They would also have to publish anonymized data comparing how admitted and rejected students did relative to these criteria.

Trump offers universities a choice: Comply for preferential funding Read More »

harvard-sues-to-block-government-funding-cuts

Harvard sues to block government funding cuts

The suit also claims that the funding hold, made in retaliation for Harvard’s letter announcing its refusal to accept these conditions, punishes Harvard for exercising free speech.

Separately, the lawsuit focuses on Title VI, part of the Civil Rights Act, which prohibits the government from funding organizations that engage in racial discrimination. It’s Harvard’s alleged tolerance for antisemitism that would enable the government to put a hold on these funds. But the suit spells out the requirements for cutting funding—hearings, a 30-day waiting period, notification of Congress—that the law requires before funding can be cut. And, quite obviously, the government has done none of them.

Harvard also alleges that the government’s decision to hold research funds is arbitrary and capricious: “The Government has not—and cannot—identify any rational connection between antisemitism concerns and the medical, scientific, technological, and other research it has frozen.”

Finally, the court is asked to consider an issue that’s central to a lot of the questions regarding Trump Administration actions: Can the executive branch stop the flow of money that was allocated by Congress? “Defendants do not have any inherent authority to terminate or freeze appropriated federal funding,” the suit claims.

Remedies

The suit seeks various remedies. It wants the government’s actions declared illegal, the freeze order vacated, and prohibitions put in place that will prevent the government from accomplishing the freeze through some other means. Harvard would also like any further reactions to allegations of antisemitism to follow the procedures mandated by Title VI and to have the government cover its attorney’s fees.

It also wants the ruling expedited, given the potential for damage to university-hosted research. The suit was filed in the District of Massachusetts, which is the same venue that has been used for other suits seeking to restrain the Trump administration’s attack on federally funded research. So far, those have resulted in rapid responses and injunctions that have put damaging funding cuts on hold. So, there’s a good chance we’ll see something similar here.

Harvard sues to block government funding cuts Read More »

after-harvard-says-no-to-feds,-$2.2-billion-of-research-funding-put-on-hold

After Harvard says no to feds, $2.2 billion of research funding put on hold

The Trump administration has been using federal research funding as a cudgel. The government has blocked billions of dollars in research funds and threatened to put a hold on even more in order to compel universities to adopt what it presents as essential reforms. In the case of Columbia University, that includes changes in the leadership of individual academic departments.

On Friday, the government sent a list of demands that it presented as necessary to “maintain Harvard’s financial relationship with the federal government.” On Monday, Harvard responded that accepting these demands would “allow itself to be taken over by the federal government.” The university also changed its home page into an extensive tribute to the research that would be eliminated if the funds were withheld.

In response, the Trump administration later put $2.2 billion of Harvard’s research funding on hold.

Diversity, but only the right kind

Harvard posted the letter it received from federal officials, listing their demands. Some of it is what you expect, given the Trump administration’s interests. The admissions and hiring departments would be required to drop all diversity efforts, with data on faculty and students to be handed over to the federal government for auditing. As at other institutions, there are also some demands presented as efforts against antisemitism, such as the defunding of pro-Palestinian groups. More generally, it demands that university officials “prevent admitting students hostile to the American values and institutions.”

There are also a bunch of basic culture war items, such as a demand for a mask ban, and a ban on “de-platforming” speakers on campus. In addition, the government wants the university to screen all faculty hires for plagiarism issues, which is what caused Harvard’s former president to resign after she gave testimony to Congress. Any violation of these updated conduct codes by a non-citizen would require an immediate report to the Department of Homeland Security and State Department, presumably so they can prepare to deport them.

After Harvard says no to feds, $2.2 billion of research funding put on hold Read More »

trump-administration’s-attack-on-university-research-accelerates

Trump administration’s attack on university research accelerates

Shortly after its inauguration, the Trump administration has made no secret that it isn’t especially interested in funding research. Before January’s end, major science agencies had instituted pauses on research funding, and grant funding has not been restored to previous levels since. Many individual grants have been targeted on ideological grounds, and agencies like the National Science Foundation are expected to see significant cuts. Since then, individual universities have been targeted, starting with an ongoing fight with Columbia University over $400 million in research funding.

This week, however, it appears that the targeting of university research has entered overdrive, with multiple announcements of funding freezes targeting several universities. Should these last for any considerable amount of time, they will likely cripple research at the targeted universities.

On Wednesday, Science learned that the National Institutes of Health has frozen all of its research funding to Columbia, despite the university agreeing to steps previously demanded by the administration and the resignation of its acting president. In 2024, Columbia had received nearly $700 million in grants from the NIH, with the money largely going to the university’s prestigious medical and public health schools.

But the attack goes well beyond a single university. On Tuesday, the Trump administration announced a hold on all research funding to Northwestern University (nearly $800 million) and Cornell University ($1 billion). These involved money granted by multiple government agencies, including a significant amount from the Department of Defense in Cornell’s case. Ostensibly, all of these actions were taken because of the university administrators’ approach to protests about the conflict in Gaza, which the administration has characterized as allowing antisemitism.

Trump administration’s attack on university research accelerates Read More »

national-institutes-of-health-radically-cuts-support-to-universities

National Institutes of Health radically cuts support to universities

Grants paid by the federal government have two components. One covers the direct costs of performing the research, paying for salaries, equipment, and consumables like chemicals or enzymes. But the government also pays what are called indirect costs. These go to the universities and research institutes, covering the costs of providing and maintaining the lab space, heat and electricity, administrative and HR functions, and more.

These indirect costs are negotiated with each research institution and average close to 30 percent of the amount awarded for the research. Some institutions see indirect rates as high as half the value of the grant.

On Friday, the National Institutes of Health (NIH) announced that negotiated rates were ending. Every existing grant, and all those funded in the future, will see the indirect cost rate set to just 15 percent. With no warning and no time to adjust to the change in policy, this will prove catastrophic for the budget of nearly every biomedical research institution.

Cut in half or more

The new policy is described in a supplemental guidance document that modifies the 2024 grant policy statement. The document cites federal regulations that allow the NIH to use a different indirect cost rate from that negotiated with research institutions for “either a class of Federal awards or a single Federal award,” but it has to justify the decision. So, much of the document describes the indirect costs paid by charitable foundations, which tend to be much lower than the rate paid by the NIH.

The new rate of indirect cost reimbursement will be applied to any newly funded grants and retroactively to all existing grants starting with the issuance of this notice. The retroactive nature of this decision may end up being challenged due to the wording of the regulations cited earlier, which also state that “The Federal agency must include, in the notice of funding opportunity, the policies relating to indirect cost rate.” However, even going forward, this will likely severely curtail biomedical research in the US.

National Institutes of Health radically cuts support to universities Read More »

alzheimer’s-scientist-indicted-for-allegedly-falsifying-data-in-$16m-scheme

Alzheimer’s scientist indicted for allegedly falsifying data in $16M scheme

Funding Scheme —

The work underpinned an Alzheimer’s drug by Cassava, now in a Phase III trial.

Alzheimer’s scientist indicted for allegedly falsifying data in $16M scheme

A federal grand jury has indicted an embattled Alzheimer’s researcher for allegedly falsifying data to fraudulently obtain $16 million in federal research funding from the National Institutes of Health for the development of a controversial Alzheimer’s drug and diagnostic test.

Hoau-Yan Wang, 67, a medical professor at the City University of New York, was a paid collaborator with the Austin, Texas-based pharmaceutical company Cassava Sciences. Wang’s research and publications provided scientific underpinnings for Cassava’s Alzheimer’s treatment, Simufilam, which is now in Phase III trials.

Simufilam is a small-molecule drug that Cassava claims can restore the structure and function of a scaffolding protein in the brain of people with Alzheimer’s, leading to slowed cognitive decline. But outside researchers have long expressed doubts and concerns about the research.

In 2023, Science magazine obtained a 50-page report from an internal investigation at CUNY that looked into 31 misconduct allegations made against Wang in 2021. According to the report, the investigating committee “found evidence highly suggestive of deliberate scientific misconduct by Wang for 14 of the 31 allegations,” the report states. The allegations largely centered around doctored and fabricated images from Western blotting, an analytical technique used to separate and detect proteins. However, the committee couldn’t conclusively prove the images were falsified “due to the failure of Dr. Wang to provide underlying, original data or research records and the low quality of the published images that had to be examined in their place.”

In all, the investigation “revealed long-standing and egregious misconduct in data management and record keeping by Dr. Wang,” and concluded that “the integrity of Dr. Wang’s work remains highly questionable.” The committee also concluded that Cassava’s lead scientist on its Alzheimer’s disease program, Lindsay Burns, who was a frequent co-author with Wang, also likely bears some responsibility for the misconduct.

In March 2022, five of Wang’s articles published in the journal PLOS One were retracted over integrity concerns with images in the papers. Other papers by Wang have also been retracted or had statements of concern attached to them. Further, in September 2022, the Food and Drug Administration conducted an inspection of the analytical work and techniques used by Wang to analyze blood and cerebrospinal fluid from patients in a simufilam trial. The investigation found a slew of egregious problems, which were laid out in a “damning” report obtained by Science.

In the indictment last week, federal authorities were explicit about the allegations, claiming that Wang falsified the results of his scientific research to NIH “by, among other things, manipulating data and images of Western blots to artificially add bands [which represent proteins], subtract bands, and change their relative thickness and/or darkness, and then drawing conclusions” based on those false results.

Wang is charged with one count of major fraud against the United States, two counts of wire fraud, and one count of false statements. If convicted, he faces a maximum penalty of 10 years in prison for the major fraud charge, 20 years in prison for each count of wire fraud, and five years in prison for the count of false statements, the Department of Justice said in an announcement.

In a statement posted to its website, Cassava acknowledged Wang’s indictment, calling him a “former” scientific adviser. The company also said that the grants central to the indictment were “related to the early development phases of the Company’s drug candidate and diagnostic test and how these were intended to work.” However, Cassava said that Wang “had no involvement in the Company’s Phase 3 clinical trials of simufilam.”

Those ongoing trials, which some have called to be halted, are estimated to include over 1,800 patients across several countries.

Alzheimer’s scientist indicted for allegedly falsifying data in $16M scheme Read More »